Top Markets
#1 EXOD EXOD +22.08%
#2 Geodnet Geodnet +17.40%
#3 Neiro Neiro +17.31%
#4 XPIN Network XPIN Network +16.45%
#5 Derive Derive +15.52%
#6 Mubarak Mubarak +14.79%
#7 AUKI AUKI +14.02%
#8 Pons Pons +13.99%
#9 Status Status +13.41%
#10 The Black Bull The Black Bull +13.26%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
U-Neuron Biomedical Inc U-Neuron Biomedical Inc

U-Neuron Biomedical Inc

6973
Rank in Stocks #25597
U-Neuron Biomedical Inc. specializes in the pioneering development of stem cell... U-Neuron Biomedical Inc. specializes in the pioneering development of stem cell technologies. The company's core activities revolve around advancing methods for stem cell preservation, isolation, and their subsequent application in therapeutic treatments. Their research specifically targets Amniotic Fluid Stem Cells, Olfactory Stem Cells, and Adipose-derived Stem Cells. This enterprise was established on September 4, 2015, and is based in New Taipei, Taiwan.
Share Price
$1.24
Market Cap
$47.99M
Change (1 day)
0.13%
Change (1 year)
3.29%
Country
TW
Trade U-Neuron Biomedical Inc (6973)

Category

Healthcare
P/B ratio for U-Neuron Biomedical Inc (6973)
P/B ratio as of 2026 TTM: 0
According to U-Neuron Biomedical Inc latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for U-Neuron Biomedical Inc from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US